Skip to content

Efficacy and safety of fu's subcutaneous needling in the treatment of low back myofascial pain syndrome: a prospective, randomized controlled trial

Construction of the clinical decline effect of floating acupuncture in the treatment of low back myofascial pain syndrome

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079147
Enrollment
Unknown
Registered
2023-12-26
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain syndrome

Interventions

Floating needle group:Floating Needle + Routine Rehabilitation
control group:Routine rehabilitation (including TENS + Tuina, etc.)

Sponsors

Shaoguan First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Patients who met the international diagnosis of myofascial pain syndrome and whose primary region was in the low back. 2) Vital signs were stable and there were no serious cardiovascular or cerebral vascular diseases. 3) Visual analogue scale (VAS) scores of >80. 4) Duration of the disease was greater than 3 months, and the age of the disease was between 18-70 years old. 5) Consent was obtained from the patients themselves and they signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) history of substance abuse (including excessive alcohol consumption), medications taken during the trial that would interfere with pain assessment; 2) skin surface infections, ulcers, or injuries; 3) coagulability disorders; 4) pregnancy, patients with needle-sickness; and 5) any other condition determined by the investigator to be likely to significantly affect the results of this trial.

Design outcomes

Primary

MeasureTime frame
visual analogue scale,VAS;numerical rating scale,NRS;Oswestry Disability Index(ODI);

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);adverse reaction rate;

Countries

China

Contacts

Public ContactZicai Liu

Shaoguan First People's Hospital

1454262065@qq.com+86 151 1551 4120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026